Dr. Reddy’s Laboratories Receives GST Demand Orders Worth ₹2.20 Crore
Dr. Reddy’s Laboratories one of India’s leading pharmaceutical companies headquartered in Hyderabad, recently made headlines after disclosing GST demand orders totalling approximately ₹2.20 crore for the financial years FY20–22. Reported widely in March 2026, this development highlights the ongoing challenges companies face under India’s complex GST regime even those with strong compliance system.
